Mccamish Mark A.'s most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 67,025 Ordinary Shares done at an average price of $21 . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 21.00 per share. | 12 Feb 2026 | 67,025 | 0 (0%) | 0% | 21 | 1,407,525 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 33,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 21.00 per share. | 12 Feb 2026 | 22,000 | 0 (0%) | 0% | 21 | 462,000 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 11,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 11,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2026 | 67,025 | 0 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2026 | 67,025 | 67,025 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 22,000 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Rafael Holdings Inc (Class B) | Mccamish Mark A. | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 60,241 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc (Class B) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 32,586 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc (Class B) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 05 Jan 2022 | 5,412 | 5,412 (0%) | 0% | 5.4 | 29,171 | Class B Common Stock, par value $.01 per share |